Data as of Aug 22
| -0.38 / -0.86%|
The 4 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 50.00, with a high estimate of 58.00 and a low estimate of 45.00. The median estimate represents a +14.50% increase from the last price of 43.67.
The current consensus among 4 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.